LY6G6D and colorectal carcinoma: Clone 10C1 was selected to study the prevalence of LY6G6D in colorectal cancer (CRC), as its staining was blocked with 50x recombinant LY6G6D protein, confirming its specificity for LY6G6D (Supplemental Fig. 2A-B).